Physician profile
Dylan Soller
NPI 1366001307
$1,441.58
in general payments reported to CMS, 2019-2025
9 companies · $558 in 2025
The $558 reported for 2025 was more than what 75% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $215 · 2020: $234 · 2021: $198 · 2023: $17.68 · 2024: $219 · 2025: $558.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $794.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $794.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $318.83 | 2021-2025 | |
| Glaxosmithkline, LLC. | $238.23 | 2019-2020 | |
| Pleural Dynamics INC. | $224.37 | 2025 | Automatic Continuous Effusion Shunt (Aces) System |
| Olympus America INC. | $184.34 | 2024-2025 | Single-Use Flexible Video Bronchoscope |
| Pulmonx Corporation | $159.87 | 2024 | Zephyr Endobronchial Valve, Chartis Catheter, Zephyr Delivery Catheter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $120.58 | 2020 | |
| Novo Nordisk INC | $90.39 | 2019 | |
| Becton, Dickinson and Company | $87.29 | 2025 | Pleurx |
| Baxter Healthcare | $17.68 | 2023 | Hillrom - Life 2000 Ventilation System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dylan Soller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.